Results 191 to 200 of about 8,697,781 (299)

Literature Review of Occult Hepatitis B Infection and Hepatitis B Core Antibody-Positive Blood Donors. [PDF]

Cureus
Thongthaisin A, Sauleda S.
europepmc   +1 more source

Quantification of Yield Loss Caused by Triticum mosaic virus and Wheat streak mosaic virus in Winter Wheat Under Field Conditions.

Plant Disease, 2014
E. Byamukama, S. Wegulo, S. Tatineni, Gary L. Hein, R. Graybosch, P. Baenziger, R. French   +6 more
semanticscholar   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

CRISPR-Cas13-based amplification-free detection of three quarantine-significant sugarcane viruses. [PDF]

Plant Cell Rep
Lagner J, Paulson A, Schulden T, Adhikari B, Koob J, Vakulskas C, Qi Y.   +6 more
europepmc   +1 more source

IMPACT OF INTERFERON SIGNALLING ON VIRUS YIELD IN MAMMALIAN CELL CULTURE-BASED INFLUENZA VACCINE PRODUCTION

IMPACT OF INTERFERON SIGNALLING ON VIRUS YIELD IN MAMMALIAN CELL CULTURE-BASED INFLUENZA VACCINE PRODUCTION Background. A well characterized factor limiting Influenza replication in vivo is the type I interferon (IFN) response. We want to analyse whether
Frensing, T., Reichl, U., Seitz, C.
core  

Seeing the invisible: How RNA extraction and library prep shape viral read recovery in RNA-seq. [PDF]

Mol Ther Adv
Afroj S, Gong B, Scholl A, Li B, Xu J, De S.   +5 more
europepmc   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

Arthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin, Candace H. Feldman, Claire E. H. Barber, Gabriel Fabreau, Jake Jennings, Scott Patten, Cheryl Barnabe, Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group   +7 more
wiley   +1 more source

Darunavir and Fosamprenavir Inhibit Zika Virus Replication via Dual Targeting of the Envelope Protein and NS2B-NS3 Protease. [PDF]

J Med Virol
Kan JY, Su HC, Lai HC, Lin YF, Chiu SW, Wu PC, Hsueh PR, Lu CH, Lin CW.   +8 more
europepmc   +1 more source

Clinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study

Arthritis Care &Research, EarlyView.
Objective In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods Electronic records of a multisite cohort (patients
Syed B. Ali, Thomas Khoo, Keeran Shivakumar, Adam Caroll, Lauren Hender, Dimitra Beroukas, Kim Griggs, Celina Jin, Theo De Malmanche, Jessica Day, Gabor Major, Vidya Limaye   +11 more
wiley   +1 more source